TY - JOUR
T1 - Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex
AU - Nottet, Hans S.L.M.
AU - Gendelman, Howard E.
N1 - Funding Information:
We thank Karen Spiegel for excellent editorial and graphic assistanceT. his work was supportedi n part by the NIH (grants PO1 NS31492-01, PO1 HL43628-05, R01 NS34239-Ol), the Charles A. Dana Foundation and the University of Nebraska Biotechnologys tart-up funds. H.S.L.M.N. is a PediatricA IDS FoundationS cholara nd a NicholasB . BadamFi ellow.H .E.G. is a Carter-WallacFee llow.
PY - 1995/9
Y1 - 1995/9
N2 - Infection of the brain with human immunodeficiency virus 1 (HIV-1) often leads to the devastating loss of mental faculties. Surprisingly, HIV-1 elicits such brain dysfunction without significantly infecting neurons, astrocytes and oligodendroglia. The target for HIV-1 in the brain is the macrophage, which usually functions as a phagocytic, antigen-presenting and immune-regulatory cell. How can these cells produce such serious cognitive and motor brain impairments? Here, Hans Nottet and Howard Gendelman propose that HIV-1 penetrates the blood-brain barrier inside differentiating macrophages, which become immune activated once inside the brain, and secrete high levels of neurotoxins. Chronic, subclinical disease results by astrocyte regulation of macrophage effector functions. Ultimately, endogenous control mechanisms break down, leading to motor and mental impairments in some affected subjects.
AB - Infection of the brain with human immunodeficiency virus 1 (HIV-1) often leads to the devastating loss of mental faculties. Surprisingly, HIV-1 elicits such brain dysfunction without significantly infecting neurons, astrocytes and oligodendroglia. The target for HIV-1 in the brain is the macrophage, which usually functions as a phagocytic, antigen-presenting and immune-regulatory cell. How can these cells produce such serious cognitive and motor brain impairments? Here, Hans Nottet and Howard Gendelman propose that HIV-1 penetrates the blood-brain barrier inside differentiating macrophages, which become immune activated once inside the brain, and secrete high levels of neurotoxins. Chronic, subclinical disease results by astrocyte regulation of macrophage effector functions. Ultimately, endogenous control mechanisms break down, leading to motor and mental impairments in some affected subjects.
UR - http://www.scopus.com/inward/record.url?scp=0029086519&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029086519&partnerID=8YFLogxK
U2 - 10.1016/0167-5699(95)80022-0
DO - 10.1016/0167-5699(95)80022-0
M3 - Article
C2 - 7546209
AN - SCOPUS:0029086519
SN - 0167-5699
VL - 16
SP - 441
EP - 448
JO - Immunology Today
JF - Immunology Today
IS - 9
ER -